Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 1,185Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Laxmi Organic Industries Ltd

02 1SCI Pharmtech

03 2Aventus Labs

04 3Kimia Biosciences

05 2Nanjing Joyin Pharmachem Co, ltd

06 1Precise Group

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLaxmi Organics is a prominent player with a record of building state-of-the-art assets to cater to the needs of a global customer base.

CAS Number : 542-08-5

End Use API : Azelnidipine

About The Company : "The Company’s product portfolio includes a wide range of products such as Acetyl Intermediates, Speciality Intermediates, and Fluorine Intermediates. These p... Since its inception, the company has maintained a constant focus on quality, innovation, sustainability, customer centricity which has enabled it to become a reliable partner for its customers." class="partyInfoTitle fa fa-info-circle" aria-hidden="true">

Laxmi Organic

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSCI Pharmtech offers high-quality, cost-effective APIs, advanced intermediates, & custom products with global expertise and precision.

CAS Number : 18621-17-5

End Use API : Azelnidipine

About The Company : SCI Pharmtech Inc. offers APIs, advanced intermediates, and custom products, focusing on quick development and cost-effective production. Our research labs, pil...

SCI Company Banner

03

STLE Annual Meeting
Not Confirmed
arrow
STLE Annual Meeting
Not Confirmed
arrow

CAS Number : 170749-59-4

End Use API : Azelnidipine

About The Company : Aventus Labs is a forward-thinking pharmaceutical company committed to developing and delivering high-quality, effective healthcare solutions. With a focus on r...

blank

04

STLE Annual Meeting
Not Confirmed
arrow
STLE Annual Meeting
Not Confirmed
arrow

CAS Number : 39562-25-9

End Use API : Azelnidipine

About The Company : Aventus Labs is a forward-thinking pharmaceutical company committed to developing and delivering high-quality, effective healthcare solutions. With a focus on r...

blank

05

STLE Annual Meeting
Not Confirmed
arrow
STLE Annual Meeting
Not Confirmed
arrow

CAS Number : 170749-59-4

End Use API : Azelnidipine

About The Company : Kimia Biosciences, established in 1993, is focused on manufacturing bulk drugs for various therapeutic segments. With a strong emphasis on excellence and advanc...

blank

06

STLE Annual Meeting
Not Confirmed
arrow
STLE Annual Meeting
Not Confirmed
arrow

CAS Number : 39562-25-9

End Use API : Azelnidipine

About The Company : Kimia Biosciences, established in 1993, is focused on manufacturing bulk drugs for various therapeutic segments. With a strong emphasis on excellence and advanc...

blank

07

STLE Annual Meeting
Not Confirmed
arrow
STLE Annual Meeting
Not Confirmed
arrow

CAS Number : 116574-09-5

End Use API : Azelnidipine

About The Company : Kimia Biosciences, established in 1993, is focused on manufacturing bulk drugs for various therapeutic segments. With a strong emphasis on excellence and advanc...

blank

08

STLE Annual Meeting
Not Confirmed
arrow
STLE Annual Meeting
Not Confirmed
arrow

CAS Number : 170749-59-4

End Use API : Azelnidipine

About The Company : We specialize in the supply of API and API related intermediates and services. A significant part of our business comes from the process/production development ...

blank

09

STLE Annual Meeting
Not Confirmed
arrow
STLE Annual Meeting
Not Confirmed
arrow

CAS Number : 18621-17-5

End Use API : Azelnidipine

About The Company : We specialize in the supply of API and API related intermediates and services. A significant part of our business comes from the process/production development ...

blank

10

STLE Annual Meeting
Not Confirmed
arrow
STLE Annual Meeting
Not Confirmed
arrow

CAS Number : 118431-04-2

End Use API : Azelnidipine

About The Company : Established in 1997, the PRECISE Group is a respected pharmaceutical company in India with an annual turnover of USD 40 million. Backed by a skilled regulatory ...

blank